Follow
Professor Usha Menon
Professor Usha Menon
MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College
Verified email at ucl.ac.uk - Homepage
Title
Cited by
Cited by
Year
Rethinking ovarian cancer: recommendations for improving outcomes
S Vaughan, JI Coward, RC Bast, A Berchuck, JS Berek, JD Brenton, ...
Nature Reviews Cancer 11 (10), 719-725, 2011
15242011
Association analysis identifies 65 new breast cancer risk loci
K Michailidou, S Lindstr÷m, J Dennis, J Beesley, S Hui, S Kar, A Lemašon, ...
Nature 551 (7678), 92-94, 2017
13782017
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
DD Bowtell, S B÷hm, AA Ahmed, PJ Aspuria, RC Bast Jr, V Beral, ...
Nature reviews Cancer 15 (11), 668-679, 2015
11912015
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
IJ Jacobs, U Menon, A Ryan, A Gentry-Maharaj, M Burnell, JK Kalsi, ...
The Lancet 387 (10022), 945-956, 2016
11792016
Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies
Collaborative Group on Hormonal Factors in Breast Cancer
The lancet oncology 13 (11), 1141-1151, 2012
11462012
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies
CL Pearce, C Templeman, MA Rossing, A Lee, AM Near, PM Webb, ...
The lancet oncology 13 (4), 385-394, 2012
11002012
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UKá…
U Menon, A Gentry-Maharaj, R Hallett, A Ryan, M Burnell, A Sharma, ...
The lancet oncology 10 (4), 327-340, 2009
10302009
Polygenic risk scores for prediction of breast cancer and breast cancer subtypes
N Mavaddat, K Michailidou, J Dennis, M Lush, L Fachal, A Lee, JP Tyrer, ...
The American Journal of Human Genetics 104 (1), 21-34, 2019
9532019
Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer
AE Teschendorff, U Menon, A Gentry-Maharaj, SJ Ramus, ...
Genome research 20 (4), 440-446, 2010
9372010
Management of women who test positive for high-risk types of human papillomavirus: the HART study
J Cuzick, A Szarewski, H Cubie, G Hulman, H Kitchener, D Luesley, ...
The Lancet 362 (9399), 1871-1876, 2003
7672003
Screening for ovarian cancer: a pilot randomised controlled trial
IJ Jacobs, SJ Skates, N MacDonald, U Menon, AN Rosenthal, AP Davies, ...
The Lancet 353 (9160), 1207-1210, 1999
7341999
New tumor markers: CA125 and beyond
RC Bast, D Badgwell, Z Lu, R Marquez, D Rosen, J Liu, KA Baggerly, ...
International Journal of Gynecologic Cancer 15 (Suppl 3), 2005
6822005
Progress and challenges in screening for early detection of ovarian cancer
IJ Jacobs, U Menon
Molecular & Cellular Proteomics 3 (4), 355-366, 2004
6822004
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ...
Nature genetics 45 (4), 371-384, 2013
6522013
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
SJ Ramus, H Song, E Dicks, JP Tyrer, AN Rosenthal, MP Intermaggio, ...
Journal of the National Cancer Institute 107 (11), djv214, 2015
5052015
Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
U Menon, A Gentry-Maharaj, M Burnell, N Singh, A Ryan, C Karpinskyj, ...
The Lancet 397 (10290), 2182-2193, 2021
4742021
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study
W Sieh, M K÷bel, TA Longacre, DD Bowtell, A DeFazio, MT Goodman, ...
The lancet oncology 14 (9), 853-862, 2013
4662013
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer
PDP Pharoah, YY Tsai, SJ Ramus, CM Phelan, EL Goode, K Lawrenson, ...
Nature genetics 45 (4), 362-370, 2013
4252013
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
CM Phelan, KB Kuchenbaecker, JP Tyrer, SP Kar, K Lawrenson, ...
Nature genetics 49 (5), 680-691, 2017
4232017
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24
EL Goode, G Chenevix-Trench, H Song, SJ Ramus, M Notaridou, ...
Nature genetics 42 (10), 874-879, 2010
3992010
The system can't perform the operation now. Try again later.
Articles 1–20